Nicardipine Hydrochloride 2.5 mg per 1 mL injection, solution

Where it's made

This label doesn't name the factory that makes the drug (it lists 1 site that tests it). Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants American Regent, Inc. names for other drugs.

Recalls

• Apr 18, 2025 · Class II · American Regent, Inc.
  Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
  Lots: Lots, expiry: Lot 24086N0C0, 7/31/2025; Lot 24076N0C0, Lot 24090N0C0, 8/31/2025, Lot 25011N0C0, 6/30/2026;

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Nicardipine: every company that makes it

Form

injection, solution, intravenous

Strength

2.5 mg per 1 mL

Approval

ANDA ANDA090534

On the market since

May 8, 2020

Package NDCs

0517-0735-01 0517-0735-10

Official label

DailyMed (National Library of Medicine), updated May 1, 2020

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?